Doctor profile · Federal record

Dr. Narin Apisarnthanarax, M.D.

Dermatology Physician (CMS: Dermatology) · Webster, TX

  • NPI 1669506663
  • Accepts Medicare
  • MIPS 90.2 / 100 · 2023
  • 28 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13938 Highway 3 Unit 100
Webster, TX 775981622
(281) 332-9681
fax (281) 332-5957
Mailing address
13938 Highway 3
Webster, TX 775981622

Credentials & registration

NPPES · NUCC
NPI registered
March 2007 — 19 yrs on file
Profile last updated
August 24, 2022
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Texas #L3233

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1669506663. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
27,816
Distinct HCPCS
10
Medicare allowed
$452,976
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 22,400 51 $2
17003 Destruction of precancer skin growth, 2-14 growths 2,062 327 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 673 506 $92
17000 Destruction of precancer skin growth, 1 growth 517 397 $50
17110 Destruction of skin growth, 1-14 growths 486 389 $114
99214 Established patient office or other outpatient visit, 30-39 minutes 350 295 $130
99203 New patient office or other outpatient visit, 30-44 minutes 261 261 $115
11102 Biopsy of related skin growth, first growth 251 216 $90
96574 Application of light with debridement to destroy precancer skin growth 102 49 $290
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 85 34 $1

In context: peer comparison

Among 2 peers in Webster Dermatology Physician, average services per provider: 712. This provider delivers 39× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,982
Transactions
170
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Revance Therapeutics, INC. 10 $552.05
Janssen Biotech, INC. 27 $521.44
Abbvie INC. 24 $455.80
Arcutis Biotherapeutics, INC. 16 $352.91
Ucb, INC. 4 $340.71
Genzyme Corporation 14 $329.79
Dermavant Sciences, INC. 16 $226.68
Regeneron Healthcare Solutions, INC. 9 $170.13
Sun Pharmaceutical Industries INC. 7 $162.15
Amgen INC. 6 $156.51
E.R. Squibb & Sons, L.L.C. 8 $140.31
Novartis Pharmaceuticals Corporation 10 $137.92
Galderma Laboratories, L.P. 12 $136.89
Incyte Corporation 5 $103.10
Leo Pharma INC. 2 $51.33

By nature of payment

Food and Beverage
$3,910
Education
$72

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
805
Patients
524
Total drug cost
$135,391
Drug Type Claims Patients Total cost
Ketoconazole Generic 137 82 $2,980
Triamcinolone Acetonide Generic 127 98 $1,982
Hydrocortisone Generic 125 101 $1,021
Doxycycline Hyclate Generic 74 45 $1,750
Fluocinonide Generic 55 30 $2,390
Doxycycline Monohydrate Generic 39 35 $419
Tacrolimus Generic 37 15 $7,882
Betamethasone Dipropionate Generic 36 31 $1,948
Clobetasol Propionate Generic 29 20 $2,696
Dupixent Pen (Dupilumab) Brand 28 0 $109,702

Frequently asked questions

Auto-generated from federal data
What is Dr. Narin Apisarnthanarax's medical specialty?
Dr. Narin Apisarnthanarax practices Dermatology Physician in Webster, TX.
Where does Dr. Narin Apisarnthanarax practice?
Dr. Narin Apisarnthanarax practices at 13938 Highway 3 Unit 100, Webster, TX 775981622. Office phone: 2813329681.
What is Dr. Narin Apisarnthanarax's NPI?
Dr. Narin Apisarnthanarax's National Provider Identifier (NPI) is 1669506663, issued by NPPES.
Does Dr. Narin Apisarnthanarax accept Medicare assignment?
Yes. Dr. Narin Apisarnthanarax accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Narin Apisarnthanarax commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.